Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04391166 · ClinicalTrials.gov registry record
Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 108
- Enrollment target
NCT04391166: Completed study, sponsored by Vanderbilt University Medical Center.
NCT04391166 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04391166 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
Prompted by the current COVID-19 pandemic, the American Academy of Ophthalmology has recommended the use of telemedicine to continue ophthalmic care while maintaining patient and provider social distancing. As part of remote examinations, patients may be expected to perform home eye testing for visual acuity and the use of various home visual acuity charts have been proposed to provide clinicians with this vital data. However, the use of home visual acuity exams has not been validated in our patient population. This project aims to determine the efficacy and validity of measuring visual acuity at home with a printed-out ETDRS chart.
Primary Outcome
Best Visual Acuity per eye
Interventions
- OTHER Non invasive visual acuity testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2020-05-20 |
| Est. Completion | 2020-12-01 |
What the finished NCT04391166 record still lists
NCT04391166 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Non invasive visual acuity testing is the first listed.
NCT04391166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04391166 about?
NCT04391166 is a clinical study titled "Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic". Prompted by the current COVID-19 pandemic, the American Academy of Ophthalmology has recommended the use of telemedicine to continue ophthalmic care while maintaining patient and provider social distancing. As part of remote examinations, patients may be expected to perform home eye testing for visu...
What is the current status of trial NCT04391166?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2020-05-20. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT04391166?
The interventions under investigation include: Non invasive visual acuity testing (OTHER).
Who is sponsoring clinical trial NCT04391166?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI